Efficacy and safety of rh‐endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh‐endostatin plus pemetrexed maintenance in non‐small cell lung cancer: A retrospective comparison with standard chemotherapy

BACKGROUND: Recombinant human endostatin (rh‐endostatin) plus standard chemotherapy in advanced non‐small cell lung cancer (NSCLC) patients has shown improved efficacy; however, it is unclear whether it is effective and safe when added to pemetrexed/cisplatin and used as maintenance therapy. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shengyu, Zuo, Lijie, He, Xiaohui, Pi, Jinping, Jin, Jun, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209785/
https://www.ncbi.nlm.nih.gov/pubmed/30152052
http://dx.doi.org/10.1111/1759-7714.12827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209785/
https://www.ncbi.nlm.nih.gov/pubmed/30152052
http://dx.doi.org/10.1111/1759-7714.12827

Ejemplares similares